The effects of antifungal agents on the morphogenetic transformation by Candida albicans in vitro

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 4, 1996, Pages 579-587

  Hawser, Stephen ^a   Francolini, Maura ^b   Islam, Khalid ^a  

^a Gruppo Lepetit SpA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; PYRROLE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; MORPHOGENESIS; NONHUMAN;

EID: 0029848089     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.4.579     Document Type: Article

References (15)

1. Barchiesi, F., Colombo, A. L., McGough, D. A. & Rinaldi, M. G. (1994). Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard. Journal of Clinical Microbiology 32, 2494-500.
2. Espinell-Ingroff, A., Kish, C. W., Kerkering, T. M., Fromtling, R. A., Bartizal, K., Galgiani, J. N. el al. (1992). Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. Journal of Clinical Microbiology 30, 3138-45.
3. Galgiani, J. N. (1993). Susceptibility testing of fungi: current status of the standardization process. Antimicrobial Agents and Chemotherapy 37, 2517-21.
4. Hawser, S. P. & Islam, K. (1996). Spectrophotometric determination of the morphogenetic transformation by synchronous Candida albicans: effects of antifungal agents. Journal of Antimicrobial Chemotherapy 38, 67-73.
5. Jansen, T., Borgers, M., van de Yen, M.-A., Xhonneux, B., Wouters, L., van Gerven, F. et al. (1991). The effects of saperconazole on the morphology of Candida albicans, Pityrosporum ovale and Trichophyton rubrum in vitro. Journal of Medical and Veterinary Mycology 29, 293-303.
6. Johnson, E. M., Barnard, M. L., Richardson, M. D. & Warnock, D. W. (1982). Effect of ketoconazole on the initial stages of germ tube formation by strains of Candida albicans. Mykosen 25, 481-6.
7. Johnson, E. M., Richardson, M. D. & Warnock, D. W. (1983). Effect of imidazole antifungals on the development of germ tubes by strains of Candida albicans. Journal of Antimicrobial Chemotherapy 12, 303-16.
8. National Committee for Clinical Laboratory Standards. (1992). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Proposed Standard M27-P. NCCLS, Villanova, PA.
9. Odds, F. C. (1988). Candida and Candidosis, 2nd edn. Balliere Tindall, London.
10. Odds, F. C., Cockayne, A., Hayward, J. & Abbott, A. B. (1985). Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae. Journal of General Microbiology 131, 2581-9.
11. Pittet, D. & Wenzel, R. P. (1995). Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Archives of Internal Medicine 155, 1177-84.
12. Rex, J. H., Pfaller, M. A., Rinaldi, M. G., Polak, A. & Galgiani, J. N. (1993). Antifungal susceptibility testing. Clinical Microbiology Reviews 6, 367-81.
13. Rogers, T. R. (1995). Epidemiology and control of nosocomial fungal infections. Current Opinion in Infectious Diseases 8, 287-90.
14. Van Cutsem, J., Van Gerven, F. & Janssen, P. A. J. (1986). The in vitro evaluation of azoles. In In Vitro and In Vivo Evaluation of Antifungal Agents (Iwata, K. & Vanden Bossche, H. Eds), pp. 51-64. Elsevier Science Publishers, Amsterdam.
15. Vanden Bossche, H. (1995). Chemotherapy of human fungal infection. In Modern Selective Fungicides. Properties, Application, Mechanism of Action (Lyr, H. Ed.). Gustav Fisher Verlag, Jena.